Improved myocardial perfusion in chronic diabetic mice by the up-regulation of pLKB1 and AMPK signaling

Journal of Cellular Biochemistry

Volumn 109, Issue 5, 2010, Pages 1033-1044

  Kusmic, Claudia ^a   L'Abbate, Antonio ^a,b   Sambuceti, Gianmario ^c   Drummond, George ^d   Barsanti, Cristina ^b   Matteucci, Marco ^b   Cao, Jian ^d   Piccolomini, Francesco ^b   Cheng, Jennifer ^d   Abraham, Nader G ^d  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Adiponectin; Coronary microcirculation; Diabetic cardiomyopathy; Endothelial dysfunction; Heme oxygenase 1

Indexed keywords

3 NITROTYROSINE; ADIPONECTIN; COBALT; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; HEME OXYGENASE; HEME OXYGENASE 1; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTOPORPHYRIN; SERINE THREONINE PROTEIN KINASE 1; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; GLUCOSE BLOOD LEVEL; HEART; HEART MUSCLE PERFUSION; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOZOCIN DIABETES; TIME; TISSUE LEVEL; UPREGULATION; WILD TYPE;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; HEME OXYGENASE-1; INJECTIONS, INTRAPERITONEAL; INSULIN; MICE; MICROCIRCULATION; MICROVESSELS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PHOSPHORYLATION; PRESSURE; PROTEIN-SERINE-THREONINE KINASES; PROTOPORPHYRINS; SIGNAL TRANSDUCTION; STREPTOZOCIN; SUPEROXIDES; TIME FACTORS; UP-REGULATION; VASCULAR RESISTANCE;

ANIMALIA; MUS;

EID: 77950428827     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22486     Document Type: Article

References (46)

1. Abraham NG, Kappas A. 2008. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79-127.
2. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, Darzynkiewicz Z, Wolin M. 2003. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93:507-514.
3. Al-Khalili L, Krook A, Zierath JR, Cartee GD. 2004. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake. Am J Physiol Endocrinol Metab 287:E553-E557.
4. Berg AH, Scherer PE. 2005. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939-949.
5. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953.
6. Canty JM, Jr., Klocke FJ. 1985. Reduced regional myocardial perfusion in the presence of pharmacologic vasodilator reserve. Circulation 71:370-377.
7. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. 2003. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026.
8. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz De Montellano PR, Kemp BE. 1999. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289.
9. Dimitrakoudis D, Vranic M, Klip A. 1992. Effects of hyperglycemia on glucose transporters of the muscle: Use of the renal glucose reabsorption inhibitor phlorizin to control glycemia. J Am Soc Nephrol 3:1078-1091.
10. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. 1999. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605.
11. Dyck JR, Lopaschuk GD. 2006. AMPK alterations in cardiac physiology and pathology: Enemy or ally? J Physiol 574:95-112.
12. Fleming I, Schulz C, Fichtlscherer B, Kemp BE, Fisslthaler B, Busse R. 2003. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets. Thromb Haemost 90:863-871.
13. Frame LH, Powell WJ, Jr. 1976. Progressive perfusion impairment during prolonged low flow myocardial ischemia in dogs. Circ Res 39:269-276.
14. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601.
15. Go YM, Boo YC, Park H, Maland MC, Patel R, Pritchard KA, Jr., Fujio Y, Walsh K, Darley-Usmar V, Jo H. 2001. Protein kinase B/Akt activates c-Jun NH(2)-terminal kinase by increasing NO production in response to shear stress. J Appl Physiol 91:1574-1581.
16. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. 2003. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28.
17. Kim JY, van de WE, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE. 2007. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
18. Kossenjans W, Eis A, Sahay R, Brockman D, Myatt L. 2000. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Phyisiol Heart Circ Physiol 278:H1311-H1319.
19. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR. 2003. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278:39422-39427.
20. Kozak AJ, Liu F, Funovics P, Jacoby A, Kubant R, Malinski T. 2005. Role of peroxynitrite in the process of vascular tone regulation by nitric oxide and prostanoids-A nanotechnological approach. Prostaglandins Leukot Essent Fatty Acids 72:105-113.
21. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, Abraham NG. 2005. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 111:3126-3134.
22. Kusmic C, Lazzerini G, Coceani F, Barsacchi R, L'Abbate A, Sambuceti G. 2006. Paradoxical coronary microcirculatory constriction during ischemia: A synergic function for nitric oxide and endothelin. Am J Physiol Heart Circ Physiol 291:H1814-H1821.
23. L'Abbate A, Neglia D, Vecoli C, Novelli M, Ottaviano V, Baldi S, Barsacchi R, Paolicchi A, Masiello P, Drummond GS, McClung JA, Abraham NG. 2007. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats. Am J Physiol Heart Circ Physiol 293:H3532-H3541.
24. LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, Tomas E. 2006. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab 291:E175-E181.
25. Milstien S, Katusic Z. 1999. Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function. Biochem Biophys Res Commun 263:681-684.
26. Mosén H, Salehi A, Henningsson R, Lundquist I. 2006. Nitric oxide inhibits, and carbon monoxide activates, islet acid a-glucoside hydrolase activities in parallel with glucose-stimulated insulin secretion. J Endocrinol 190:681-693.
27. Musi N, Goodyear LJ. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes2002. Curr Drug Targets Immune Endocr Metabol Disord 2:119-127.
28. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. 2005. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 289:H2144-H2152.
29. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I. 2006. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47:1108-1116.
30. Oltman CL, Richou LL, Davidson EP, Coppey LJ, Lund DD, Yorek MA. 2006. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 291:H1780-H1787.
31. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K. 2004. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279:1304-1309.
32. Peterson SJ, Husney D, Kruger AL, Olszanecki R, Ricci F, Rodella LF, Stacchiotti A, Rezzani R, McClung JA, Aronow WS, Ikehara S, Abraham NG. 2007. Long-term treatment with the apolipoprotein A1 mimetic Peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther 322:514-520.
33. Ramlal T, Rastogi S, Vranic M, Klip A. 1989. Decrease in glucose transporter number in skeletal muscle of mildly diabetic (streptozotocin- treated) rats. Endocrinology 125:890-897.
34. Reihill JA, Ewart MA, Hardie DG, Salt IP. 2007. AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Biochem Biophys Res Commun 354:1084-1088.
35. Rodella LF, Peterson SJ, Drummond G, Rezzani R, Falck JR, Abraham NG. 2008. Heme oxygenase-derived carbon monoxide restores adiponectin levels and vascular function in type 1 diabetes. Drug Metab Lett 2:290-300.
36. Sambuceti G, Marzilli M, Marraccini P, Schneider-Eicke J, Gliozheni E, Parodi O, L'Abbate A. 1997. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation 95:2652-2659.
37. Sambuceti G, Marzilli M, Fedele S, Marini C, L'Abbate A. 2001. Paradoxical increase in microvascular resistance during tachycardia downstream from a severe stenosis in patients with coronary artery disease: Reversal by angioplasty. Circulation 103:2352-2360.
38. Sambuceti G, Marzilli M, Mari A, Marini C, Schluter M, Testa R, Papini M, Marraccini P, Ciriello G, Marzullo P, L'Abbate A. 2005. Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischemic myocardium. Am J Physiol Heart Circ Physiol 288:H2298-H2305.
39. Schildknecht S, Ullrich V. 2009. Peroxynitrite as regulator of vascular prostanoid synthesis. Arch Biochem Biophys 484:183-189.
40. Schulz E, Dopheide J, Schuhmacher S, Thomas SR, Chen K, Daiber A, Wenzel P, Munzel T, Keaney JF, Jr. 2008. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 118:1347-1357.
41. Skurk C, Maatz H, Kim HS, Yang J, Abid MR, Aird WC, Walsh K. 2004. The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem 279:1513-1525.
42. Sun JF, Phung T, Shiojima I, Felske T, Upalakalin JN, Feng D, Kornaga T, Dor T, Dvorak AM, Walsh K, Benjamin LE. 2005. Microvascular patterning is controlled by fine-tuning the Akt signal. Proc Natl Acad Sci USA 102:128-133.
43. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang CC, Itani SI, Lodish HF, Ruderman NB. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99:16309-16313.
44. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, Ikehara S, Wolin MS, Abraham NG. 2005. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 289:H701-H707.
45. Wang ZV, Scherer PE. 2008. Adiponectin, cardiovascular function, and hypertension. Hypertension 51:8-14.
46. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. 2003. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13:2004-2008.